{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:33:15Z","timestamp":1793298795250,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["AGBORE20Q10"],"award-info":[{"award-number":["AGBORE20Q10"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268201800082P"],"award-info":[{"award-number":["HHSN268201800082P"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016875","name":"Chimerix","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019123","name":"AiCuris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.healun.2021.05.012","type":"journal-article","created":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T10:21:16Z","timestamp":1622370076000},"page":"1454-1462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury"],"prefix":"10.1016","volume":"40","author":[{"given":"Katrina","family":"Bazemore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rohly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitipong","family":"Permpalung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Timofte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Whitney","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Orens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin K","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Valantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pali D","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2021.05.012_bib0001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-016-0529-6","article-title":"Infectious triggers of chronic lung allograft dysfunction","volume":"18","author":"Gregson","year":"2016","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.healun.2021.05.012_bib0002","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2009.04.022","article-title":"Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1","volume":"28","author":"Burton","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0003","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.200608-1079OC","article-title":"Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome","volume":"175","author":"Daud","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2021.05.012_bib0004","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/TP.0b013e31816651de","article-title":"Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome","volume":"85","author":"Botha","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.012_bib0005","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.00128607","article-title":"Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?","volume":"31","author":"Vos","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.05.012_bib0006","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-2006-954612","article-title":"Infections after lung transplantation","volume":"27","author":"Avery","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2021.05.012_bib0007","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1600-6143.2011.03490.x","article-title":"Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies","volume":"11","author":"Vu","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0008","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ajt.14042","article-title":"Epidemiology and immediate indirect effects of respiratory viruses in lung transplant recipients: a 5-year prospective study","volume":"17","author":"Peghin","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-0030-1249120","article-title":"Viral infections in lung transplant recipients","volume":"31","author":"Shah","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2021.05.012_bib0010","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/TP.0000000000002985","article-title":"Oral and inhaled ribavirin treatment for respiratory syncytial virus infection in lung transplant recipients","volume":"104","author":"Permpalung","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.05.012_bib0011","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ajt.15687","article-title":"Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation","volume":"20","author":"Kulkarni","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0012","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/ajt.13029","article-title":"Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS","volume":"15","author":"Gregson","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0013","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.transproceed.2017.11.080","article-title":"Bacterial infections during hospital stay and their impact on mortality after lung transplantation: a single-center study","volume":"50","author":"Wojarski","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2021.05.012_bib0014","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-3062.2009.00422.x","article-title":"Clinical spectrum of gram-positive infections in lung transplantation","volume":"11","author":"Gupta","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.05.012_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ebiom.2018.12.029","article-title":"Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation","volume":"40","author":"Agbor-Enoh","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.healun.2021.05.012_bib0016","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0017","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2021.05.012_bib0018","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-5223(98)70168-0","article-title":"Adenovirus infection in the lung results in graft failure after lung transplantation","volume":"116","author":"Bridges","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2021.05.012_bib0019","series-title":"Transplant Proc","article-title":"Microbiological status as a factor of airway complications after lung transplantation","author":"N\u0119cki","year":"2020"},{"key":"10.1016\/j.healun.2021.05.012_bib0020","first-page":"479","article-title":"Paramyxovirus infection in lung transplant recipients","volume":"14","author":"Wendt","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2014.12.021","article-title":"Role of rhinovirus load in the upper respiratory tract and severity of symptoms in lung transplant recipients","volume":"64","author":"Ambrosioni","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.healun.2021.05.012_bib0022","doi-asserted-by":"crossref","first-page":"e13422","DOI":"10.1111\/tid.13422","article-title":"Epidemiology and persistence of rhinovirus in pediatric lung transplantation","author":"Ammerman","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.healun.2021.05.012_bib0023","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12866-018-1231-7","article-title":"Impact of gram negative bacteria airway recolonization on the occurrence of chronic lung allograft dysfunction after lung transplantation in a population of cystic fibrosis patients","volume":"18","author":"Orfanos","year":"2018","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.healun.2021.05.012_bib0024","doi-asserted-by":"crossref","first-page":"e13511","DOI":"10.1111\/ctr.13511","article-title":"American society of transplantation infectious diseases community of practice. rna respiratory viral infections in solid organ transplant recipients: guidelines from the american society of transplantation infectious diseases community of practice","volume":"33","author":"Manuel","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0025","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/cid\/ciy1047","article-title":"Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction","volume":"69","author":"Peghin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.healun.2021.05.012_bib0026","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.healun.2019.12.009","article-title":"Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection","volume":"39","author":"Gunasekaran","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0027","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1111\/ctr.12054","article-title":"Rhinovirus and other respiratory viruses exert different effects on lung allograft function that are not mediated through acute rejection","volume":"27","author":"Sayah","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0028","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0029","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.05.012_bib0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0031","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.healun.2017.05.026","article-title":"Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation","volume":"36","author":"Agbor-Enoh","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0032","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2021.05.012_bib0033","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/rccm.200310-1359OC","article-title":"Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death","volume":"170","author":"Khalifah","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2021.05.012_bib0034","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.healun.2008.11.907","article-title":"Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome","volume":"28","author":"Valentine","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2021.05.012_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821023263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249821023263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:02:59Z","timestamp":1778796179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249821023263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1053249821023263"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.05.012","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}